Epstein Secrets

said Monday that the Senate "will take up and pass a mammoth defense bill despite a looming veto showdown with President Trump." McConnell included the National Defense Authorization Act on a list of "items left on Congress's year-end to-do list as lawmakers prepare to leave Washington for the year as soon as next week." Roll Call <

FDA will take its signal from the advisory committee and hopefully we'll see an authorization very soon after." Asked about skeptics of the vaccine, Giroir said, "Corners we've cut are only to take financial risks. Instead of doing things sequentially, the government has invested billions of dollars int

Assistant HHS Secretary for Health Adm. Brett Giroir: "I think we could be causing a lot more harm by causing overly restrictive recommendations." Giroir said on Fox News' America's Newsroom <https://video.foxnews.com/v/6214668517001? playlist_id=903354961001#sp=show-clips> (12/7, 896K), "What really

irector Fauci: "When you have a challenge to the healthcare system, you have got to do something like that." Assistant HHS Secretary for Health Adm. Brett Giroir: "I think we could be causing a lot more harm by causing overly restrictive recommendations." Giroir said on Fox News' America's Newsroom <https://

member Rep. Elise Stefanik (R-NY) "said at least 22 of the more than 50 legislative proposals from the report were included in the final version of the National Defense Authorization Act passed by the House." Those provisions must still "survive a conference with the Senate and a potential veto from the White House, which has already

corn/b94bdd0202d14e13b934a2c1658d824c?pubid=fbi> , Giroir "said he could not recommend hydroxychloroquine" because trials "do not show any benefit." Giroir said, "We need to move on from that and talk about what is effective." Giroir "suggested that doctors would be unlikely to prescribe the drug." Gir

o.cotn/news/2020/08/02/trump-health-official-hydroxychloroquine-390601> (8/2, Warmbrodt, 4.29M) reports that Assistant HHS Secretary for Health Adm. Brett Giroir "said Sunday there is no evidence that hydroxychloroquine is an effective treatment for the virus, despite President Donald Trump's continued promo

/www.axios.corn/senate-defense-act-trumps-veto-d2898e46-ee4d-4641-823b-911bae016021.html> (7/23, Ayesh, 521K) reports the Senate on Thursday "passed the National Defense Authorization Act on Thursday on an 86-14 <https://wwvv.senate.govflegislative/LIS/roll_call_lists/roll_call_vote_cfm.cfm? congress=116&session=2&vote=00140> vote,"

sp=show-clips> (7/23, 11:43 a.m. ET, I.59M), HHS Assistant Secretary for Health Adm. Brett Giroir was asked about delayed COVID-19 testing results. Giroir said, "We need to do everything we can to reduce the turnaround time, but let me put it in a little bit of context. About half the tests in the coun

member Rep. Elise Stefanik (R-NY) "said at least 22 of the more than 50 legislative proposals from the report were included in the final version of the National Defense Authorization Act passed by the House." Those provisions must still "survive a conference with the Senate and a potential veto from the White House, which has alread

he anti-malaria drug." On NBC's Meet The PressVi, Giroir "said he could not recommend hydroxychloroquine" because trials "do not show any benefit." Giroir said, "We need to move on from that and talk about what is effective." Giroir "suggested that doctors would be unlikely to prescribe the drug." Giro

member Rep. Elise Stefanik (R-NY) "said at least 22 of the more than 50 legislative proposals from the report were included in the final version of the National Defense Authorization Act passed by the House." Those provisions must still "survive a conference with the Senate and a potential EFTA01658049 veto from the White House, w

drug." On NBC's Meet The PressVi, Giroir "said he could not recommend hydroxychloroquine" because EFTA01658055 trials "do not show any benefit." Giroir said, "We need to move on from that and talk about what is effective." Giroir "suggested that doctors would be unlikely to prescribe the drug." Giro